Making weight-loss drug semaglutide costs just $3/month: Study
Technology
A new study found that making injectable semaglutide, the trendy weight-loss jab, costs as little as $3 a month. Even the pill form is just $16 to produce.
But in the US branded semaglutide is priced at about $200 a month (for examples such as Wegovy).
Findings could spark debate on ethical pricing of medications
Obesity and diabetes are huge global problems, especially in lower-income countries where most cases exist.
Yet high prices keep these drugs out of reach for many who need them most.
The study highlights how affordable treatments could be if prices reflected actual production costs rather than current market prices.